# Study To Evaluate The Effect Of A Multiple Oral Dose Of PF-00232798 On QT Intervals In Healthy Subjects

> **NCT01140425** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 44 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-00232798
- **DRUG:** PF-00232798
- **DRUG:** Placebo
- **DRUG:** Moxifloxacin

## Key facts

- **NCT ID:** NCT01140425
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2010-12-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01140425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01140425, "Study To Evaluate The Effect Of A Multiple Oral Dose Of PF-00232798 On QT Intervals In Healthy Subjects". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01140425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*